AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.

Clinical Trials

Pharmaceutical

Biotechnology

AdvanCell Isotopes Pty Ltd

Andrew Adamovich

Michael Tung

Sheruna Naidoo

Vanessa Worsfold

Thomas Kryza

Simon Puttick

Sheridan Martin

Nicolò Canever

Kevin Kuan

Julian F. Kelly

The Leadership Team at AdvanCell Isotopes Pty Ltd guides the company's strategic direction, oversees the development and commercialization of their Targeted Alpha Therapy platform technology, ensures robust financial health, and fosters innovation in nuclear and chemical sciences to advance cutting-edge cancer treatments.

Leadership Team

Research and Development

��

Leadership Team

About

Team members

Other teams at AdvanCell Isotopes Pty Ltd

Research and Development

��������

Leadership Team

About

Team members

Other teams at AdvanCell Isotopes Pty Ltd

Research and Development

��